Tuesday, March 17, 2026

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Elon Musk’s Trump Endorsement Boosts Tesla, Nvidia Left Behind

Nvidia saw a slight drop in its stock price despite an upward revision of its target price by an investment firm.

Park Ji Won Criticizes Yoon Suk Yeol: ‘Don’t Worry About the First Lady… She’ll Be There Soon’

Rep. Park Ji Won criticizes President Yoon for his insensitivity amid personal and national concerns, urging a focus on the country's future.

Tag: Appeal

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.